I am thrilled to share that I have stepped into the role of Founder Director at Prothix Lifesciences Pvt Ltd. This new chapter is driven by a vision to revolutionize clinical research and drug development through the power of data analytics and artificial intelligence.At Prothix, we are committed to leveraging advanced analytics to streamline the drug development process, enhance clinical trial efficiency, and uncover deeper insights into patient outcomes. By harnessing AI technologies, we aim to transform vast datasets into actionable intelligence, enabling more informed decision-making and accelerating the path from discovery to market.Our goal is to create innovative solutions that not only improve the speed and efficacy of drug development but also ensure that treatments are tailored to the specific needs of patients. We believe that the future of healthcare lies in data-driven approaches, and we are excited to be at the forefront of this transformation.I look forward to connecting with fellow professionals, researchers, and innovators as we embark on this exciting journey. Together, let's shape the future of life sciences!#ProthixLifesciences #ClinicalResearch #DrugDevelopment #DataAnalytics #AI #HealthcareInnovation

At Ethix Pharma, my technical and research leadership, successfully guided the company toward achieving strategic goals within fiscal parameters. By efficiently managing a multidisciplinary team, we increased project delivery efficiency by 30% over the past three years and reduced operational costs by 20% without compromising research quality. We completed over 125 preclinical, toxicological, and clinical research projects in natural products, biotechnology, pharmaceuticals, and medical devices on time and within budget, achieving a 95% project completion success rate, minimizing delays and accelerating time-to-market for clients' products. I facilitated the publication of over 15 research papers in high-impact international journals, significantly enhancing the company's reputation. Our continuous review of business operations led to a 25% increase in client satisfaction and a 15% growth in repeat business. By strengthening partnerships with governments, academia, and other stakeholders, we established 10 new collaborative research projects, resulting in a 50% increase in collaborative efforts. Our strategic alignment of corporate culture with improved employee retention by 40% and overall productivity by 30%. As an advisor to national and state governments, my insights into medicinal plants, natural product development, traditional medicine, Indigenous Knowledge, and biodiversity influenced public health policies and initiatives. We achieved a 90% success rate in meeting KPIs and project milestones through effective project monitoring, evaluation, and reporting. Our efforts in developing the company's research profile attracted top talent and competitive funding, leading to a 35% increase in research grants and funding. Our cost-effective solutions and efficient financial management strategies resulted in a 20% reduction in overall project costs, enhancing client ROI with a 25% increase in satisfaction and 15% growth in repeat business.

At Noble Research Foundation (NRF), I provided strong academic and philanthropic leadership, advancing various development sectors aligned with Sustainable Development Goals (SDGs). I spearheaded initiatives in health and well-being, education, livelihood, certification, agriculture, scientific and action research, innovation, environmental sustainability, climate action, and biodiversity. I successfully led the development and implementation of a strategic plan, aligning with NRF’s mission and vision. This enhanced research quality, facilitated over five high-impact projects, increased research output by 30%, and garnered over $10,000 in competitive funding. I optimized resources, reducing operational costs by 15% through strategic realignment. Conducting ongoing business operations reviews, I improved value propositions for shareholder and increased satisfaction by 20%. By identifying and capitalizing on new business opportunities, I boosted annual revenue by 15%. As the spokesperson for NRF, I enhanced the organization's visibility and reputation, promoting the brand nationally and internationally. I ensured compliance with statutory, legal, and regulatory requirements and implemented robust risk management practices. Attracting over 10 renowned researchers, I increased NRF’s research capacity by 20%. I facilitated external relations with universities, the National Health Agency, hospitals, and government entities, securing an additional $25,000 in funding. I effectively deployed strategic funds, improving translational research quality by 35%. I developed comprehensive annual and long-term budgets, ensuring sustainable financial strategies. These accomplishments reflect my commitment to advancing NRF’s mission, fostering a culture of excellence with significant impact in various SDGs. Through strategic leadership, effective stakeholder engagement, and a focus on sustainability, NRF’s growth and success, positioned it as a leader in R&D aligned with SDGs.

Successfully managed and resolved over 2,000 medical information enquiries, ensuring accurate and timely responses to healthcare professionals (HCPs) and the public, while streamlining the adverse event (AE) and adverse drug reaction (ADR) reporting processes, reducing response times by 20% and ensuring 100% regulatory compliance. Enhanced the Medical Information Database by incorporating new scientific materials, leading to a 15% increase in the quality and scope of information available to HCPs. Efficiently identified, reported, and followed up on adverse events and product quality complaints within the stipulated timelines, achieving a 98% on-time reporting rate. Coordinated and conducted quarterly drug safety review meetings, resulting in improved communication and faster resolution of safety issues, and implemented a robust tracking system for CIOMS forms, ensuring complete and accurate documentation before managerial review. Monitored and updated SPC, PIL, and other medical documents, contributing to successful product registrations and renewals in multiple countries. Played a key role in the development and execution of pharmacovigilance activities and risk management plans, maintaining consistent data flow to meet PV compliance, and maintained meticulous records and audit trails in line with Clinical Expert Statement (CES) guidelines and Periodic Safety Update Reports (PSUR), ensuring high standards of accuracy and compliance. Reviewed and validated over 500 claims, promotional materials, and publications, ensuring they were backed by solid scientific and medical evidence, and led the training and development of a 10-member team, providing mentorship and guidance aligned with organizational goals and company policies. Additionally, provided comprehensive administrative and technical support to the UK Medical Director & Medical Affairs Department, enhancing overall departmental efficiency and performance.

Successfully managed and executed over 15 pre-clinical research projects, significantly enhancing the company's pharmacology capabilities. Supervised and designed laboratory experiments, leading to the discovery of 3 new pharmacological targets, and ensured a 95% accuracy rate in analyzing and reporting results. Maintained 100% compliance with regulatory standards, overseeing daily project operations and adherence to all compliance requirements. In clinical research coordination, developed and wrote comprehensive trial protocols for 10 projects, presenting them successfully to steering and ethics committees. Identified and assessed 8 clinical trial sites, ensuring their suitability and adherence to industry standards, and designed data collection forms (CRFs) that improved data accuracy and reliability by 20%.Managed ethics and regulatory aspects by coordinating with ethics committees to safeguard trial subjects' rights and achieving a 100% approval rate for protocols. Handled regulatory authority applications and approvals for 5 drugs, facilitating timely market entry, and collaborated with 12 investigators and healthcare professionals to enhance trial quality and compliance. Set up and monitored 10 clinical trial sites, ensuring each site had necessary materials and met standards. Trained over 50 site staff to trial-specific standards, increasing trial efficiency by 25%. Conducted regular site visits for monitoring, achieving a 98% data accuracy rate through meticulous source data verification (SDV). Authored detailed visit reports, maintained comprehensive trial documentation, and contributed to the successful closure of 8 trial sites. Collaborated with medical statisticians on trial results, leading to the publication of 4 technical trial reports and manuscripts.